BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12835741)

  • 1. Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia.
    Ribatti D; Molica S; Vacca A; Nico B; Crivellato E; Roccaro AM; Dammacco F
    Leukemia; 2003 Jul; 17(7):1428-30. PubMed ID: 12835741
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation of bone marrow angiogenesis and mast cells with tryptase activity in myelodysplastic syndromes.
    Ribatti D; Polimeno G; Vacca A; Marzullo A; Crivellato E; Nico B; Lucarelli G; Dammacco F
    Leukemia; 2002 Sep; 16(9):1680-4. PubMed ID: 12200681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tryptase-positive mast cells predict clinical outcome of patients with early B-cell chronic lymphocytic leukemia.
    Molica S; Vacca A; Crivellato E; Cuneo A; Ribatti D
    Eur J Haematol; 2003 Aug; 71(2):137-9. PubMed ID: 12890156
    [No Abstract]   [Full Text] [Related]  

  • 4. Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies.
    Wilkins BS; Buchan SL; Webster J; Jones DB
    Histopathology; 2001 Aug; 39(2):150-5. PubMed ID: 11493331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer.
    Ribatti D; Finato N; Crivellato E; Marzullo A; Mangieri D; Nico B; Vacca A; Beltrami CA
    Am J Obstet Gynecol; 2005 Dec; 193(6):1961-5. PubMed ID: 16325597
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy.
    Samorapoompichit P; Schernthaner GH; Worda C; Wimazal F; Krauth MT; Sperr WR; Valent P
    Histopathology; 2006 Feb; 48(3):247-57. PubMed ID: 16430471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.
    Ibaraki T; Muramatsu M; Takai S; Jin D; Maruyama H; Orino T; Katsumata T; Miyazaki M
    Eur J Cardiothorac Surg; 2005 Oct; 28(4):617-21. PubMed ID: 16125954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M; Harvima IT
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical characterization of mast cell disease in paraffin sections using tryptase, CD68, myeloperoxidase, lysozyme, and CD20 antibodies.
    Li WV; Kapadia SB; Sonmez-Alpan E; Swerdlow SH
    Mod Pathol; 1996 Oct; 9(10):982-8. PubMed ID: 8902835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural examination of tryptase-, and VIP-positive mast cells in the common bile duct of patients with lithiasis.
    Gulubova M; Vodenicharov A
    Acta Histochem; 2001 Oct; 103(4):437-52. PubMed ID: 11700949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Tryptase--an sign of mastocyte activation].
    Wrzyszcz M; Dobek R; Medrala W; Wolańczyk-Medrala A
    Pneumonol Alergol Pol; 1996; 64(5-6):366-70. PubMed ID: 8924893
    [No Abstract]   [Full Text] [Related]  

  • 12. Tryptase concentrations in bronchoalveolar lavage from patients with chronic eosinophilic pneumonia.
    Bargagli E; Bigliazzi C; Leonini A; Nikiforakis N; Perari MG; Rottoli P
    Clin Sci (Lond); 2005 Mar; 108(3):273-6. PubMed ID: 15537394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis and mast cell density with tryptase activity increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas.
    Ribatti D; Vacca A; Marzullo A; Nico B; Ria R; Roncali L; Dammacco F
    Int J Cancer; 2000 Jan; 85(2):171-5. PubMed ID: 10629073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells expressing chymase but not tryptase can be derived by culturing human progenitors in conditioned medium obtained from a human mastocytosis cell strain with c-kit ligand.
    Li L; Meng XW; Krilis SA
    J Immunol; 1996 Jun; 156(12):4839-44. PubMed ID: 8648132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of angiogenesis in chronic lymphocytic leukemia.
    Smolej L; Benesova P
    Cancer; 2006 Dec; 107(11):2742-3; author reply 2743. PubMed ID: 17066484
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunocytochemical localization of mast cells in lymphocytic hypophysitis.
    Vidal S; Rotondo F; Horvath E; Kovacs K; Scheithauer BW
    Am J Clin Pathol; 2002 Mar; 117(3):478-83. PubMed ID: 11888089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy and mast cell activation.
    Carlos AG; Carlos ML; Santos MA; Pedro E; Santos S; Lopes-Pregal A
    Allerg Immunol (Paris); 1998 Oct; 30(8):257-8. PubMed ID: 9846195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tryptase-positive mast cells correlate with angiogenesis in canine mammary carcinoma.
    Im KS; Kim JH; Yhee JY; Yu CH; Kim NH; Nho WG; Sur JH
    J Comp Pathol; 2011; 144(2-3):157-63. PubMed ID: 20934709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in B-cell chronic lymphocytic leukemia: methods of study, clinical significance and prognostic implications.
    Molica S
    Leuk Lymphoma; 2001 Aug; 42(4):603-7. PubMed ID: 11697488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Choice of endothelial marker is crucial for assessment of bone marrow microvessel density in chronic lymphocytic leukemia.
    Smolej L; Kasparová P
    APMIS; 2008 Dec; 116(12):1058-62. PubMed ID: 19133008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.